Article
Contribution of activin receptor-like kinase 5 (transforming growth factor beta receptor type I) signaling to the fibrotic phenotype of scleroderma fibroblasts.
Arthritis and rheumatism - 1 Apr 2006
Chen Yunliang, Shi-wen Xu, Eastwood Mark, Black Carol M, Denton Christopher P, Leask Andrew, Abraham David J
Abstract excerpt
OBJECTIVE: To use a specific transforming growth factor beta receptor type I (TGFbetaRI; activin receptor-like kinase 5 [ALK-5]) kinase inhibitor (SD208) to determine the role of activation of the TGFbetaRI kinase (ALK-5) in maintaining the profibrotic phenotype of dermal fibroblasts in systemic sclerosis (SSc). METHODS: The effect of SD208 on the expression of key biochemical markers of the fibrotic phenotype...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
